Gonadrenalina (Gnrh) + Tamoxifene Nella Terapia Della Infertilità Idiopatica

Aparicio N. J. , Schwarzenstein L. , Turner E. A. , Turner D. , Mancini R. , Schally A. V. : Treatment of idiopathic normogonadotropic oligoasthenospermia with syntetic luteinizing hormone releasing hormone. Fertil. & Steril., 27; 549–555 (1976).

Busolo F. , Zanchetta R. , Bertoloni G. : Mycoplasmic localization patterns on spermatozoa from infertile men. Fertil. & Steril., 42; 412–417 (1984).

Buvat J. , Ardaens K. , Lemaire A. , Gautier Gashault J. P. , Harhaut M. B. : Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen. Fertil. & Steril., 99; 700–703 (1983).

Conti G. , Isidori A. : Trattato di andrologia. Piccin Editore, Padova 1984.

Dafau M. L. , Cirrage S. , Baukal A. J. , Sorrel S. , Bator J. M. , Neubauer J. F. , Catt J. K. : Androgen biosintesis in Leydig cells after testicular desensitization by luteneizing hormone releasing hormone and human chorionic gonadotropin. Endocrinology, 105; 1314–1317 (1979).

Hannonai Z. T. , Peled M. , Paz G. F. : Changes in semen quality and fertility in response to endocrine treatment of subfertile men. Gynecol. Obst. Invest., 9; 244–255 (1978).

Harper H. J. K. , Walpole A. L. : Contrasting endocrine activity of cis- and trans-isomers in a series of substitutes triphenylethylenes. Nature, 212; 87–88 (1966).

Helfonson S. , Wilking N. , Carlstrom K. , Damber M. G. , von Schaultz B. : A comparative study of the estrogenic effects of tamoxifen and 17-β-estradiol in postmenopausal women. J. Clin. Endocrinol. Metab., 54; 404–408 (1982).

Lison L. : Statistica applicata alla biologia sperimentale. Casa Editrice Ambrosiana, Milano 1974.

Lippshultz L. I. , Kaufman J. J. : Subfertility. In: Current urologic therapy. A cura di Lippshultz L. I. , Kaufman J. J. , p. 399–420. W. B. Saunders Company, Philadelphia 1980.

Lippshultz L. I. , Renter D. L. : Evaluation and treatment of male infertility. Monogr. Urol., vol. 7, aprile-maggio 1986.

Margalioth E. J. , Lauger N. , Persitz M. D. , Gaulaiev B. , Shemesh A. , Schenker J. G. : Treatment of oligoasthenospermia with human chorionic gonatropin: hormonal profiles and results. Fertil. & Steril., 39; 841–844 (1983).

McClure R. D. : Drug therapy for idiopathic infertility. In: Contemporary management of infertility and impotence. A cura di Tanagho E. A. , Lue T. F. , CcClure R. D. , p. 290–301. William & Wilkins, Baltimore 1988.

Paolucci D. , Spera G. , Conte D. , Sacco G. , Comonaca A. , Isidori A. : Effects of GnRH analogues in human testis. Intern. Symposium on pituitary hormones and human peptides. S. Marino 1981.

Schill W. B. , Landthaler M. : Tamoxifen treatment of male infertility. Andrologia, 12; 56–548 (1980).

Schill W. B. , Jüngst D. , Unterburger P. , Braun S. : Combined hMG-hCG treatment in subfertile men with idiopathic normogonadotrophic oligozoospermia. Intern. J. Androl., 5; 467–477 (1982).

Sharpe R. M. , Fraser H. M. , Cooper I. , Rommer B. F. F. G. : Sertoli-Leydig cell communication via LH-RH-like factor. Nature, 290; 785–786 (1981).

Smals A. G. H. , Pieters G. F. F. H. , Drayer G. J. M. , Boers G. H. J. , Benraad T. H. J. , Kloppenbørgh T. W. L. : Tamoxifen suppresses gonadotropin induced 17-α-idrossiprogesterone in normal men. J. Endocrinol. Metab., 51; 1026–1029 (1980).

Vance M. L. , Thorner M. O. : Medical treatment of male infertility. Semin. Urol., 2; 115–119 (1984).

Van Zyl J. , Menkveld R. , Lukatz T. J. : Oligospermia a 7 year survey of incidence, chromosomal aberrations, treatment and pregnancy rate. Intern. J. Fertil., 20; 129–134 (1975).

Vermuelen A. , Comhaire F. : Hormonal effects of antiestrogen tamoxifen in normal and oligospermic men. Fertil & Steril., 29; 320–323 (1979).

Willis K. J. , London D. R. , Bevis M. A. , Butt W. R. , Lynch S. S. , Holder G. : Hormonal effects of tamoxifen in oligospermic men. J. Endocrinol., 73; 171–173 (1977).

Winters J. J. , Janick J. J. , Loriaux D. L. , Richard I. S. : Studies of the role of sex steroides in the feed-back control of gonadotropin concentration in men. II. Use of estrogen antagonist clomiphene citrate. J. Clin. Endocrinol. Metab., 48; 222–226 (1979).